Gold-assay market disruptor Chrysos Corporation has increased the value of contracts for PhotonAssay units by nearly 30% since the end of the June quarter, announcing this week the total had climbed to A$705 million (US$500m) on the back of new scheduled deployments to Canada.
Eric Sprott-backed Britannia Mining Solutions, formed earlier this year as a self-funded subsidiary of Canadian Securities Exchange-listed microcap, Britannia Life Sciences, has ordered 10 more PhotonAssay units to go with the two bought previously.
This content is available to Paid Subscribers only. If you are already a subscriber, login using the panel below or visit our Subscribe page to view subscription packages and/or Subscribe now.